Literature DB >> 2152587

Interactions between HIV and the host immune system in the pathogenesis of AIDS.

M Tersmette1, F Miedema.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2152587

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  7 in total

1.  Recombination-mediated changes in coreceptor usage confer an augmented pathogenic phenotype in a nonhuman primate model of HIV-1-induced AIDS.

Authors:  Yoshiaki Nishimura; Masashi Shingai; Wendy R Lee; Reza Sadjadpour; Olivia K Donau; Ronald Willey; Jason M Brenchley; Ranjini Iyengar; Alicia Buckler-White; Tatsuhiko Igarashi; Malcolm A Martin
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

2.  Syncytium-inducing (SI) phenotype suppression at seroconversion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population.

Authors:  M Cornelissen; G Mulder-Kampinga; J Veenstra; F Zorgdrager; C Kuiken; S Hartman; J Dekker; L van der Hoek; C Sol; R Coutinho
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

3.  Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population.

Authors:  H Schuitemaker; M Koot; N A Kootstra; M W Dercksen; R E de Goede; R P van Steenwijk; J M Lange; J K Schattenkerk; F Miedema; M Tersmette
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

4.  MT-2 cell tropism as prognostic marker for disease progression in human immunodeficiency virus type 1 infection.

Authors:  A Karlsson; K Parsmyr; E Sandström; E M Fenyö; J Albert
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

5.  Defining the fitness of HIV-1 isolates with dual/mixed co-receptor usage.

Authors:  Immaculate L Nankya; Denis M Tebit; Awet Abraha; Fred Kyeyune; Richard Gibson; Oyebisi Jegede; Gabrielle Nickel; Eric J Arts
Journal:  AIDS Res Ther       Date:  2015-10-03       Impact factor: 2.250

6.  Clonal analysis of HIV-1 genotype and function associated with virologic failure in treatment-experienced persons receiving maraviroc: Results from the MOTIVATE phase 3 randomized, placebo-controlled trials.

Authors:  Marilyn Lewis; Julie Mori; Jonathan Toma; Mike Mosley; Wei Huang; Paul Simpson; Roy Mansfield; Charles Craig; Elna van der Ryst; David L Robertson; Jeannette M Whitcomb; Mike Westby
Journal:  PLoS One       Date:  2018-12-26       Impact factor: 3.240

7.  Mucosal transmissibility, disease induction and coreceptor switching of R5 SHIVSF162P3N molecular clones in rhesus macaques.

Authors:  Wuze Ren; Alexandra Mumbauer; Ke Zhuang; Carole Harbison; Heather Knight; Susan Westmoreland; Agegnehu Gettie; James Blanchard; Cecilia Cheng-Mayer
Journal:  Retrovirology       Date:  2013-01-31       Impact factor: 4.602
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.